Entry Detail


General Information

Database ID: LDA0000858
Species: Homo sapiens
Confidence Score: 0.731059
Contents: >> ncRNA Information
>> ncRNA Association Statistics
>> Disease Information
>> Disease Association Statistics
>> Evidence Support
>> Reference
Causality: Yes
Clinical Significance: Unknown

 


ncRNA Information

Reference Genome Note: GRCh38 for human lncRNAs; GRCm39 for mouse lncRNAs; mRatBN7.2 for rat lncRNAs; hg19 for human circRNAs; mm9 for mouse circRNAs.

ncRNA Symbol:H19
Full Name:H19, imprinted maternally expressed transcript
Category:LncRNA
Species:Mus musculus
Synonyms:EyeLinc6
Chromosome:7
Strand:-
Coordinate:
Start Site(bp):142129267End Site(bp):142131883
External Links:
Ensembl ID:ENSMUSG00000000031
Ensembl Transcript ID:N/A
Entrez Gene:14955.0
NONCODE ID:N/A
RefSeq Accession:NR_130973.1

 

ncRNA Association Statistics

Total Associated Disease Number:214   
More Information
Causal Disease Number:122
Network:
Top Causal Diseases:
Stomach Neoplasms  (Score: 1)
Glioma  (Score: 1)
Glioma  (Score: 1)
Carcinoma, Hepatocellular  (Score: 1)
Colorectal Neoplasms  (Score: 1)
Breast Neoplasms  (Score: 1)
Breast Neoplasms  (Score: 1)
Stomach Neoplasms  (Score: 1)
Carcinoma, Hepatocellular  (Score: 1)
Colorectal Neoplasms  (Score: 1)
More Information

 

 

Disease Information

 Disease OntologyMeSH
Disease ID:DOID:7693D017544
Disease Name:abdominal aortic aneurysmAortic Aneurysm, Abdominal
Category:Disease OntologyMeSH
Type:Cardiovascular Diseases
Define:An aortic aneurysm that is located_in the abdominal aorta.An abnormal balloon- or sac-like dilatation in the wall of the ABDOMINAL AORTA which gives rise to the visceral, the parietal, and the terminal (iliac) branches below the aortic hiatus at the diaphragm.
Alias:AORTIC ANEURYSM, FAMILIAL ABDOMINAL 1Aortic Aneurysm, Abdominal//Abdominal Aortic Aneurysms//Aneurysm, Abdominal Aortic//Abdominal Aortic Aneurysm//Abdominal Aorta Aneurysm//Abdominal Aorta Aneurysms//Aorta Aneurysm, Abdominal//Aneurysm, Abdominal Aorta

 

Disease Association Statistics

Total Associated ncRNA Number:22   
More Information
Causal ncRNA Number:22
Network:
Top Causal ncRNAs:
PVT1  (Score: 0.731059)
H20  (Score: 0.731059)
Gas5  (Score: 0.731059)
SENCR  (Score: 0.731059)
SBF2-AS1  (Score: 0.731059)
RBM33  (Score: 0.731059)
SNHG5  (Score: 0.731059)
TP53COR1  (Score: 0.731059)
hsa_circ_0087352  (Score: 0.731059)
H19  (Score: 0.731059)
More Information

 

Evidence Support

Strong Evidence:Western Blot//qRT-PCR//Luciferase Report Assay//ELISA//IHC
Weak Evidence:

 

Reference

[1] PubMed ID:30991034
Disease Name:Aortic Aneurysm, Abdominal
Sample:AAA tissues
Dysfunction Pattern:Interaction[H19/let-7a/IL-6]
Validated Method:Western Blot//qRT-PCR//Luciferase Report Assay//ELISA//IHC
Description: qRT-PCR detected the upregulation of H19 in human and mouse AAA tissue samples.In vivo overexpression of H19 increased vascular inflammation and induced AAA formation, which was supported by exacerbated aortic morphology, maximum aortic diameter values, elastin degradation, expression of interleukin-6 (IL-6) and macrophage chemoattractant protein-1 (MCP-1), and macrophage infiltration. H19 suppression resulted in the opposite effects. A rescue experiment indicated that IL-6 neutralization significantly mitigated the aortic inflammation and AAA formation evoked by H19 overexpression. Luciferase reporter assays and ex vivo experiments using VSMCs and macrophages confirmed that H19 induced aneurysm formation in part via endogenous competition with the let-7a microRNA to induce the transcription of its target gene, IL-6. This mechanism was further validated by in vivo experiments using a mutant H19 that could not effectively bind let-7a. Collectively, our study revealed a pathogenic H19/let-7a/IL-6 inflammatory pathway in AAA formation, which offers a new potential therapeutic strategy for AAA.
Causality:Yes
Causal Description:In vivo overexpression of H19 increased vascular inflammation and induced AAA formation, which was supported by exacerbated aortic morphology, maximum aortic diameter values, elastin degradation, expression of interleukin-6 (IL-6) and macrophage chemoattractant protein-1 (MCP-1), and macrophage infiltration.
Clinical-realted Application: